Clinical Study
Effects of Ezetimibe/Simvastatin and Rosuvastatin on Oxidative Stress in Diabetic Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
Figure 3
Screening levels and changes from screening in (a) neuropathic symptoms score (NSC), (b) neuropathic disability score (NDS), and (c) analog pains scale (APS) score after 16 weeks of treatment. Data is expressed as mean ± SEM, versus week 0, and versus week 0 (baseline), Wilcoxon matched-pairs signed-rank test.
(a) |
(b) |
(c) |